High import reliance: 90 to 100 percent for medical devices, 70 to 100 percent for pharmaceuticals amid aging population and rising chronic disease prence.
Phased market entry strategy: Pre-briefings → Local clinical trial/validation at five hospitals → Exhibition and targeted marketing.
With nine out of ten medical devices used in Africa relying on imports, South Korean diagnostic and imaging equipment manufacturers are establishing a stronghold in South Africa to penetrate the broader African healthcare market.
The Ministry of Trade, Industry and Resources (MOTIR, Minister Kim Jeong-kwan) and the Korea Trade-Investment Promotion Agency (KOTRA, President Kang Kyung-sung), alongside the Korea Medical Devices Industry Association (Chairman Kim Young-min) and the Korea International Trade Association (Chairman Yoon Jin-sik), jointly organized a Korea Pavilion at 'World Health Exhibition (WHX) Johannesburg 2026' held from October 6 for a three-day run at the Gallagher Convention Centre in Johannesburg, South Africa. A total of 32 South Korean firms participated, including eight on-site exhibitors and 24 sample-exhibiting companies.
Africa relies almost entirely on imports for medical equipment. Local manufacturing remains limited to basic consumables such as syringes and cotton gauze, while import dependency for medical devices spans between 90 and 100 percent depending on the product category. Finished pharmaceuticals rely on imports for 70 to 100 percent of supply, while vaccines reach a 99 percent import reliance rate. Demographic aging and the rising incidence of chronic illness are further expanding healthcare demand across the continent. The population aged 60 and older in Sub-Saharan Africa grew from 43 million in 2010 to 67 million in 2025, and is projected to reach 163 million by 2050. Consequently, demand for diagnostic and laboratory equipment for chronic disease management and early detection is accelerating.
WHX stands as Africa's premier medical and diagnostic equipment exhibition, drawing around 600 participating companies from over 60 countries and approximately 8,000 healthcare professionals this year. Global medical equipment leaders, including Siemens Healthineers and Roche Diagnostics, convened alongside hospital administrators, clinical testing institutions, and medical device distributors and procurement officials from across Africa.
Prior to the exhibition, KOTRA provided step-by-step entry support ranging from regulatory licensing to local validation. On June 26, KOTRA co-hosted the 'Korea-Africa Biohealth Cooperation Project' in Johannesburg with the South African Laboratory Diagnostics Association (SALDA), bringing together regulatory authorities including the South African Health Products Regulatory Authority (SAHPRA), the Botswana Medicines Regulatory Authority (BOMRA), and the Zambia Medicines Regulatory Authority (ZAMRA). Officials from these regulatory bodies briefed Korean firms on national product registration procedures and International Quality Management System standards (ISO 13485).
Jang Choong-sik, Director General of KOTRA’s Africa Regional Headquarters, stated, "The African medical device market cannot be opened through product quality alone; suppliers must concurrently navigate entry hurdles spanning regulatory approval, health insurance inclusion, and public procurement. We will expand non-visiting marketing formats to showcase products to local buyers while providing comprehensive support across licensing, local validation, and corporate matchmaking."
Source:KOTRA (2026.10.12.)










